The Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL: Updated Results from the DUO Crossover Extension Study
- Matthew S. Davids
- , Bryone J. Kuss
- , Peter Hillmen
- , Marco Montillo
- , James Essell
- , Nicole Lamanna
- , Zsolt Nagy
- , Constantine S. Tam
- , Stephan Stilgenbauer
- , Paolo Ghia
- , Julio Delgado
- , NgocDiep Le
- , Stephanie Lustgarten
- , David T. Weaver
- , Ulrich Jaeger
Research output: Contribution to journal › Meeting Abstract › peer-review